1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > 2013 Analysis of the European Pap Smear/HPV Market

2013 Analysis of the European Pap Smear/HPV Market

  • June 2013
  • -
  • Venture Planning Group
  • -
  • 235 pages

Complete report $2,850. DataPack (test volumes, sales forecasts) $1,850.

This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales forecasts by country and market segment.
The report examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Contains 235 pages and 11 tables

Table Of Contents

2013 Analysis of the European Pap Smear/HPV Market
Table of Contents

I. Introduction
II. Pap Smear/HPV Worldwide Market and Technology Overview
A. Pap Smear/HPV: Clinical Significance
and Laboratory Practices
B. Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
- Chemiluminescence
- Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
H. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
a. CT
b. MRI
c. NMR
d. PET
e. Photonics Spectroscopy
C. Personal Testing
France: Test Volume and Sales Forecast
by Market Segment
Germany: Test Volume and Sales Forecast
by Market Segment
Italy: Test Volume and Sales Forecast
by Market Segment
Spain: Test Volume and Sales Forecast
by Market Segment
U.K.: Test Volume and Sales Forecast
by Market Segment
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Cancer Diagnostic Product Suppliers
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca/Nuvelo
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio/Innogenetics
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech
- Kyowa Medex
- Life Technologies
- Mackay Life Sciences
- Myriad Genetics
- Nanogen Elitech
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen/Ipsogen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics and Therapeutics
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila



List of Tables

Major Companies Developing or Marketing Pap Smear/HPV Tests
France
Pap Smear Test Volume and Diagnostics Sales
by Market Segment
France
Papillomavirus (HPV) Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany
Pap Smear Test Volume and Diagnostics Sales
by Market Segment
Germany
Papillomavirus(HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy
Pap Smear Test Volume and Diagnostics Sales
by Market Segment
Italy
Papillomavirus(HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain
Pap Smear Test Volume and Diagnostics Sales
by Market Segment
Spain
Papillomavirus (HPV) Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K.
Pap Smear Test Volume and Diagnostics Sales
by Market Segment
U.K.
Papillomavirus(HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan

2016 Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan

  • $ 3500
  • Industry report
  • September 2016
  • by Venture Planning Group

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...

2016-2021 Future Horizons and Growth Strategies in the Global Pap Smear/HPV Testing Market: Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

2016-2021 Future Horizons and Growth Strategies in the Global Pap Smear/HPV Testing Market: Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 3500
  • Industry report
  • November 2016
  • by Venture Planning Group

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...

2016 Europe Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--France, Germany, Italy, Spain, UK

2016 Europe Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--France, Germany, Italy, Spain, UK

  • $ 1836
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $2,850.  DataPack (test volumes, sales forecasts) $1,850.This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.